Related Experiment Videos
Diabetes screening in Basrah, Iraq: a population-based cross-sectional study
Abbas Ali Mansour1, Header Laftah Wanoose, Ibrahem Hani
1Department of Medicine, Basrah College of Medicine, Hattin Post Office, P.O. Box 142, Basrah 42002, Iraq. aambaam@yahoo.com
Diabetes Research and Clinical Practice
|September 5, 2007
Summary
This study found a 7.43% prevalence of diabetes and 2.02% for impaired fasting glucose (IFG) in Basrah, Iraq. These findings highlight the significant burden of abnormal glycemia in the region.
Area of Science:
- Public Health
- Endocrinology
- Epidemiology
Background:
- Noncommunicable diseases pose a significant public health challenge in the Eastern Mediterranean region.
- The study addresses the growing concern of diabetes mellitus and impaired fasting glucose (IFG) in Southern Iraq.
- Establishing baseline data is crucial for understanding and managing the diabetes epidemic.
Purpose of the Study:
- To determine the prevalence of abnormal glycemia, including diagnosed diabetes, undiagnosed diabetes, and IFG.
- To assess the prevalence of these conditions in the adult non-pregnant population (≥20 years) of Basrah, Southern Iraq.
- To utilize the American Diabetes Association (ADA) criteria for diagnosis and classification.
Main Methods:
- A cross-sectional, population-based study was conducted in al-Madina, a rural area near Basrah.
- Home-based screening for diabetes occurred during a vaccination program from April to May 2007.
- Diabetes was diagnosed based on fasting plasma glucose (FPG) ≥126 mg/dl on two occasions; IFG was defined as FPG 100-125 mg/dl.
Main Results:
- A total of 3176 individuals were surveyed, with a mean age of 43.17 years.
- The combined prevalence of known and undiagnosed diabetes was 7.43% (undiagnosed: 2.14%; known: 5.29%).
- Impaired fasting glucose (IFG) was present in 2.02% of the population, with abnormal glycemia (diabetes and IFG) affecting 9.45%.
Conclusions:
- This research provides the first baseline epidemiological data on diabetes mellitus and IFG in Basrah, Iraq.
- The observed prevalence rates fall within the reported range for the Middle East.
- The findings underscore the need for targeted public health interventions to address abnormal glycemia in the region.